AI-ECG Platform vs Sleepiz One+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Shenzhen Carewell Electronics Co., Ltd.
VS
by Sleepiz

AI Verdict

The AI-ECG Platform is designed for in-depth, AI-powered analysis and diagnosis of 12-lead resting ECGs, focusing on specific cardiovascular diseases. In contrast, Sleepiz One+ offers contactless remote patient monitoring, primarily measuring respiration and heart rate for chronic conditions and sleep apnea screening. While both utilize AI and address cardiac health to some extent, their core functionalities and deployment scenarios are distinct, making them adjacent rather than direct competitors.

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if your clinical setting requires highly accurate, AI-powered interpretation of 12-lead resting ECGs to assist physicians in diagnosing major cardiovascular diseases like arrhythmias, myocardial ischemia, and myocardial infarction. It is particularly well-suited for hospitals and healthcare facilities seeking to reduce physician workload and enhance diagnostic accuracy and efficiency in ECG analysis.

View AI-ECG Platform →

Choose Sleepiz One+ if…

Choose Sleepiz One+ if you need a contactless remote patient monitoring solution for continuous, long-term tracking of respiration rate and heart rate in adult patients, especially for senior care or managing chronic conditions. This device is ideal for home environments or clinical settings where non-invasive monitoring and sleep apnea screening are crucial, allowing for data access and analysis via a web application.

View Sleepiz One+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-ECG Platform Sleepiz One+
Pricing Contact for pricing Contact for pricing
Deployment Workstation (with GPU), web-based portal, Windows-based diagnostic client Wall-mounted or bedside table placement, Wi-Fi connectivity
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Sleepiz One+

Sleepiz One+ emphasizes ease of use with a contactless, wall-mounted or bedside device that requires minimal setup (under 5 minutes) and no wearables, making it highly user-friendly for patients across a wide age range (20-80+). The AI-ECG Platform, while offering web-based and desktop clients, involves a workstation with a GPU and compatibility with various ECG machines, suggesting a more complex setup and operational overhead.

Clinical Value

Sleepiz One+

Sleepiz One+ offers continuous, contactless monitoring of respiration and heart rate, with validated accuracy against polysomnography for sleep apnea screening and respiratory rate measurements. This provides ongoing insights into chronic conditions and early detection of deterioration. The AI-ECG Platform focuses on rapid, highly accurate interpretation of 12-lead resting ECGs for diagnosing major cardiovascular diseases, which is valuable for acute diagnostics, but Sleepiz One+'s continuous monitoring for chronic conditions offers broader long-term clinical utility.

Pricing & Value

Tie

Both tools require contacting the company for pricing, limiting transparency. Sleepiz One+ highlights that physicians can reimburse its use through CPT codes for remote patient monitoring, offering a clear path to financial value for providers. While AI-ECG platforms can be cost-effective in reducing diagnostic costs, specific reimbursement details for the AI-ECG Platform are not provided.

Enterprise Readiness

Sleepiz One+

Sleepiz One+ explicitly states HIPAA compliance and has a Business Associate Agreement (BAA) in place, which are crucial for enterprise adoption in healthcare. It also highlights easy setup and deployment with automatic cellular data transmission, reducing IT integration burden. While the AI-ECG Platform is FDA-cleared and offers various deployment options, explicit mentions of HIPAA compliance and BAA are not readily available in the provided information, though it is likely.

Innovation

Sleepiz One+

Sleepiz One+ utilizes contactless radar technology for remote patient monitoring, which is a significant innovation in patient comfort and data collection, moving away from traditional wearables. The AI-ECG Platform offers advanced AI for ECG analysis, which is innovative in its diagnostic accuracy and speed, but contactless vital sign monitoring represents a more disruptive approach to patient care.

Support & Docs

Sleepiz One+

Sleepiz One+ provides readily accessible support information including email and phone contacts, quick start guides, and an instruction manual on their website. They also mention user feedback being incorporated into development. Information regarding specific support channels or comprehensive documentation for the AI-ECG Platform is less detailed, with only a general customer service contact provided by the parent company.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-ECG Platform Sleepiz One+
Primary Function AI automatic analysis and diagnosis system for 12-lead resting ECG Contactless remote patient monitoring device for respiration and heart rate
Company Shenzhen Carewell Electronics Co., Ltd. Sleepiz
Key Measurements/Diagnoses Arrhythmias, ventricular hypertrophy, myocardial ischemia, myocardial infarction, abnormal ST-T changes. Respiration rate, heart rate, sleep apnea screening, patient presence, body movements.
Accuracy Over 95% accuracy in diagnosing major cardiovascular diseases. 99% accuracy in breathing rate and 96% in heart rate measurements compared to gold-standard methods.
Data Formats Supported Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG. Not specified
Specialties Cardiology, Emergency Medicine, Internal Medicine Geriatrics, Pulmonology, Sleep Medicine
Contactless Monitoring No Yes (radar technology).
Speed of Analysis Approximately 3 seconds for rapid diagnosis Not specified

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Platform and Sleepiz One+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The AI-ECG Platform is designed to assist physicians in interpreting 12-lead resting ECGs, integrating with existing ECG platforms and EHRs to enable advanced AI deployment and insights within clinical workflows. It supports various ECG data formats, including HL7 aECG and DICOM ECG. Sleepiz One+ is a contactless remote patient monitoring device that integrates into remote patient monitoring and clinical study platforms, allowing healthcare professionals to access overnight vital sign data and presence logs via a web application.
The AI-ECG Platform boasts over 95% accuracy in diagnosing major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, with rapid diagnosis in approximately 3 seconds. Sleepiz One+ has demonstrated 99% accuracy in breathing rate and 96% accuracy in heart rate measurements compared to gold-standard methods. For sleep apnea screening, studies show a correlation between Sleepiz-AHI and PSG-AHI of 0.94 with SpO2 and 0.87 without, with sensitivity and specificity reaching 88% and 98% respectively with an SpO2 sensor.
The AI-ECG Platform is primarily suited for Cardiology, Emergency Medicine, and Internal Medicine, assisting in the rapid and accurate interpretation of 12-lead ECGs for various cardiac conditions. Sleepiz One+ is designed for Geriatrics, Pulmonology, and Sleep Medicine, offering contactless monitoring of respiration and heart rate for chronic conditions and sleep apnea screening, particularly beneficial for immobile or infectious patients.
While specific details on the learning curve for the AI-ECG Platform are not provided, its design to assist in interpretation and integrate with existing systems suggests it aims to augment current workflows. Sleepiz One+ is described as easy to install and use, offering continuous, uninterrupted, and accurate health status checks at the bedside, implying a minimal learning curve for patients and caregivers, and a straightforward web application for healthcare professionals.
The AI-ECG Platform's web-based management portal includes features for organization settings, security, and task management, which would typically encompass audit trail functionalities. For Sleepiz One+, the web application provides access to overnight vital sign data and presence logs for healthcare professionals, suggesting that data access and analysis are logged, which is crucial for accountability and supporting clinical decisions.
The AI-ECG Platform offers a web-based management portal for organization settings and task management, which can facilitate standardized deployment and data oversight across multiple sites. Sleepiz One+ provides a web application for data access and analysis, making it suitable for remote patient monitoring and potentially streamlining data management for multi-site clinical trials or distributed care models.
The AI-ECG Platform is beneficial for any patient requiring a 12-lead resting ECG, particularly in settings where rapid and accurate diagnosis of cardiovascular diseases like arrhythmias, ischemia, and hypertrophy is critical. Sleepiz One+ is particularly advantageous for patients with chronic respiratory conditions, sleep disorders, and the elderly, enabling contactless, continuous monitoring of respiration and heart rate at home, and can be especially useful for immobile or infectious patients.

Backers

Who funded each tool's parent company.

Sleepiz One+

AI Tool Finder
AI-powered search. Results may not be comprehensive.